ArticleCancer immunology, immunotherapy : CII2019

Checkpoint blockade immunotherapy enhances the frequency and effector function of murine tumor-infiltrating T cells but does not alter TCRβ diversity.

Lindsey M Kuehm et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.